硼替佐米治疗多发性骨髓瘤后发生的严重肺部并发症：一种未被认识的肺血管炎？ - Suppr

Suppr

超能文献

Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?

作者信息

Pitini Vincenzo, Arrigo Carmela, Altavilla Giuseppe, Naro Claudia

出版信息

Leuk Res. 2007 Jul;31(7):1027-8. doi: 10.1016/j.leukres.2006.09.015. Epub 2006 Nov 28.

DOI:10.1016/j.leukres.2006.09.015

PMID:17134751

Abstract

摘要

相似文献

Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?硼替佐米治疗多发性骨髓瘤后发生的严重肺部并发症：一种未被认识的肺血管炎？

Leuk Res. 2007 Jul;31(7):1027-8. doi: 10.1016/j.leukres.2006.09.015. Epub 2006 Nov 28.

Severe pulmonary complications after bortezomib treatment in multiple myeloma.硼替佐米治疗多发性骨髓瘤后的严重肺部并发症

Hematol Oncol. 2010 Mar;28(1):49-52. doi: 10.1002/hon.924.

Pulmonary fibrosis in a myeloma patient on bortezomib treatment. A new severe adverse effect of a new drug.硼替佐米治疗的骨髓瘤患者出现肺纤维化。一种新药的新型严重不良反应。

Am J Hematol. 2007 Jun;82(6):502-3. doi: 10.1002/ajh.20891.

Optimizing bortezomib treatment in patients with relapsed multiple myeloma.优化复发多发性骨髓瘤患者的硼替佐米治疗方案。

Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 8; suppl 13.

Use of intrapleural bortezomib in myelomatous pleural effusion.胸膜内使用硼替佐米治疗骨髓瘤性胸腔积液。

Br J Haematol. 2007 Nov;139(4):621-2. doi: 10.1111/j.1365-2141.2007.06735.x.

Hyperlipidemia in a myeloma patient after bortezomib treatment.硼替佐米治疗后骨髓瘤患者出现高脂血症。

Leuk Res. 2010 Sep;34(9):e250. doi: 10.1016/j.leukres.2010.03.025. Epub 2010 Apr 3.

Bortezomib increases survival of patients with relapsed multiple myeloma.硼替佐米可提高复发型多发性骨髓瘤患者的生存率。

Health News. 2005 Sep;11(9):9.

Bortezomib-induced Sweet syndrome.硼替佐米诱发的斯威特综合征。

Br J Haematol. 2005 Oct;131(2):142. doi: 10.1111/j.1365-2141.2005.05636.x.

Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.硼替佐米治疗多发性骨髓瘤后发生严重表皮坏死松解症。

Acta Haematol. 2007;118(2):65-7. doi: 10.1159/000102604. Epub 2007 May 15.

[Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical Hematology].[日本复发/难治性多发性骨髓瘤中硼替佐米治疗相关的肺损伤：日本血液学会和日本临床血液学会“硼替佐米所致肺损伤”联合委员会基于问卷调查的报告]

Rinsho Ketsueki. 2006 Dec;47(12):1521-7.

引用本文的文献

Bortezomib induces Rho-dependent hyperpermeability of endothelial cells synergistically with inflammatory mediators.硼替佐米与炎症介质协同诱导内皮细胞的Rho依赖性高通透性。

BMC Pulm Med. 2024 Dec 18;24(1):617. doi: 10.1186/s12890-024-03387-x.

Bortezomib induced pulmonary toxicity: a case report and review of the literature.硼替佐米诱导的肺毒性：一例病例报告及文献综述

Am J Blood Res. 2020 Dec 15;10(6):407-415. eCollection 2020.

Bortezomib-induced diffuse alveolar hemorrhage in a patient with plasma cell leukemia.硼替佐米诱发浆细胞白血病患者弥漫性肺泡出血。

Respir Med Case Rep. 2020 Jul 21;31:101169. doi: 10.1016/j.rmcr.2020.101169. eCollection 2020.

Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report.硬肿性黏液水肿并发多发性骨髓瘤致严重但可逆转的肺动脉高压：病例报告。

BMC Pulm Med. 2020 Jan 9;20(1):8. doi: 10.1186/s12890-019-1020-6.

Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature.硼替佐米诱导的肺毒性：一例病例报告及文献综述

Case Rep Med. 2018 Nov 25;2018:2913124. doi: 10.1155/2018/2913124. eCollection 2018.

Anticancer therapy and lung injury: molecular mechanisms.抗癌治疗与肺损伤：分子机制。

Expert Rev Anticancer Ther. 2018 Oct;18(10):1041-1057. doi: 10.1080/14737140.2018.1500180. Epub 2018 Jul 23.

Bortezomib-induced severe pulmonary complications in multiple myeloma: A case report and literature review.硼替佐米诱发的多发性骨髓瘤严重肺部并发症：一例报告及文献综述

Oncol Lett. 2016 Mar;11(3):2255-2260. doi: 10.3892/ol.2016.4204. Epub 2016 Feb 8.

Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: incidence, mortality and clinical characterization.硼替佐米治疗相关肺部疾病在日本多发性骨髓瘤患者中的发病情况、死亡率和临床特征。

Cancer Sci. 2014 Feb;105(2):195-201. doi: 10.1111/cas.12335. Epub 2014 Jan 21.

Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma.骨髓中的基质细胞在多发性骨髓瘤患者接受硼替佐米治疗后引发发热的促炎细胞因子分泌中起重要作用。

Int J Hematol. 2008 Nov;88(4):396-402. doi: 10.1007/s12185-008-0194-0. Epub 2008 Nov 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验